GLAXOSMITHKLINE PHARMA A/S: Financial statements 2020
CVR: 27394019
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 441,702,000 and a net result of DKK 12,271,000 compared with DKK 11,096,000 the year before. That is an increase of 5.8% compared with the year before. The profit margin was 2.8%. Equity in the 2020 report amounted to DKK 37,794,000. The solvency ratio was 23.6%. The company had 62 employees in the financial year.
- Revenue
- DKK 441,702,000
- Gross Profit
- DKK 120,336,000
- Profit/Loss
- DKK 12,271,000
- Equity
- DKK 37,794,000
- Total Assets
- DKK 160,064,000
- Employees
- 62
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 441.7 mio. | 120.3 mio. | 12.3 mio. | 37.8 mio. | 62 |
| 2019 | 417.4 mio. | 114.3 mio. | 11.1 mio. | 35.5 mio. | 68 |
| 2018 | 413.8 mio. | 116.3 mio. | 17.5 mio. | 39.4 mio. | 80 |
| 2017 | 426.9 mio. | 124.4 mio. | 9.6 mio. | 35.4 mio. | 87 |
| 2016 | 366.5 mio. | 81.8 mio. | 1.9 mio. | 25.8 mio. | 92 |
Official annual report
How creditworthy is GLAXOSMITHKLINE PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 30, 2020, Tetiana Luczkiw has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of September 30, 2020, Ole Jensen-Dahm has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2020, Anne Margaret Belcher has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2020, Neale Andrew Belson has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2019. Revenue came to DKK 417,448,000, and the net result was DKK 11,096,000.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.